Turning stealth liposomes into cationic liposomes for anticancer drug delivery
Targeting the anticancer agents selectively to cancer cells is desirable to improve the efficacy and to reduce the side effects of anticancer therapy. Previously reported passive tumor targeting by PEGylated liposomes (stealth liposomes) have resulted in their higher tumor accumulation. However thei...
Main Author: | |
---|---|
Format: | Others |
Published: |
Scholarly Commons
2013
|
Subjects: | |
Online Access: | https://scholarlycommons.pacific.edu/uop_etds/147 https://scholarlycommons.pacific.edu/cgi/viewcontent.cgi?article=1146&context=uop_etds |